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Abstract
Antigenic variation plays a vital role in the pathogenesis of many infectious bacteria and protozoa including Borrelia
burgdorferi, the causative agent of Lyme disease. VlsE, a 35 kDa surface-exposed lipoprotein, undergoes antigenic variation
during B. burgdorferi infection of mammalian hosts, and is believed to be a critical mechanism by which the spirochetes
evade immune clearance. Random, segmental recombination between the expressed vlsE gene and adjacent vls silent
cassettes generates a large number of different VlsE variants within the infected host. Although the occurrence and
importance of vlsE sequence variation is well established, little is known about the biological mechanism of vlsE
recombination. To identify factors important in antigenic variation and vlsE recombination, we screened transposon
mutants of genes known to be involved in DNA recombination and repair for their effects on infectivity and vlsE
recombination. Several mutants, including those in BB0023 (ruvA), BB0022 (ruvB), BB0797 (mutS), and BB0098 (mutS-II),
showed reduced infectivity in immunocompetent C3H/HeN mice. Mutants in ruvA and ruvB exhibited greatly reduced rates
of vlsE recombination in C3H/HeN mice, as determined by restriction fragment polymorphism (RFLP) screening and DNA
sequence analysis. In severe combined immunodeficiency (C3H/scid) mice, the ruvA mutant retained full infectivity;
however, all recovered clones retained the ‘parental’ vlsE sequence, consistent with low rates of vlsE recombination. These
results suggest that the reduced infectivity of ruvA and ruvB mutants is the result of ineffective vlsE recombination and
underscores the important role that vlsE recombination plays in immune evasion. Based on functional studies in other
organisms, the RuvAB complex of B. burgdorferi may promote branch migration of Holliday junctions during vlsE
recombination. Our findings are consistent with those in the accompanying article by Dresser et al., and together these
studies provide the first examples of trans-acting factors involved in vlsE recombination.
Citation: Lin T, Gao L, Edmondson DG, Jacobs MB, Philipp MT, et al. (2009) Central Role of the Holliday Junction Helicase RuvAB in vlsE Recombination and
Infectivity of Borrelia burgdorferi. PLoS Pathog 5(12): e1000679. doi:10.1371/journal.ppat.1000679
Editor: Jenifer Coburn, Medical College of Wisconsin, United States of America
Received June 3, 2009; Accepted November 4, 2009; Published December 4, 2009
Copyright:  2009 Lin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The project described was supported by Award Numbers R01AI37277 and R01AI059048 (to S.J.N.) from the National Institute of Allergy and Infectious
Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy And
Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Steven.J.Norris@uth.tmc.edu
. These authors contributed equally to this work.
Introduction
Lyme borreliosis is a multi-stage, systemic disease caused by
members of the spirochete genus Borrelia, including Borrelia
burgdorferi in North America and Borrelia afzelii, Borrelia garinii, and
B. burgdorferi in Eurasia [1]. Spirochetes are transmitted to
mammalian and avian hosts via the bite of hard-bodied ticks of
Ixodes genus [2] and disseminate widely throughout the body in the
first weeks of infection. If untreated in early stages, chronic and
debilitating disease can develop in the skin, joints, heart, and
central nervous system [1]. Infected individuals develop an active
immune response to the pathogen yet are unable to clear the
infection.
A common mechanism of immune evasion is antigenic
variation, a process by which pathogens alter surface exposed
antigenic proteins [3,4]. The resulting variant organisms are
immunologically distinct from parental strains and thereby gain a
selective advantage over individuals that retain parental antigenic
determinants. Bacteria that undergo antigenic variation often
cause long term or repeated infections. Examples of such bacteria
include Neisseria gonorrhoeae, Neisseria meningitidis, Borrelia hermsii,
Treponema pallidum, Campylobacter jejuni, Mycoplasma synoviae, Myco-
plasma pulmonis, and Anaplasma marginale.
Lyme disease Borrelia possess the vls (Variable Major Protein
(VMP)-like sequence) system, a robust antigenic variation mech-
anism involving DNA recombination at the locus that expresses the
surface exposed lipoprotein VlsE [5,6,7,8,9]. The vls locus consists
of the vlsE expression site and a contiguous array of 15 vls silent
cassettes, which have homology to the central region of the
expression site. Gene conversion events involving replacement of
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cassettes occur continuously during mouse infection, resulting in a
myriad of vlsE sequence variants in each infected animal [10,11].
Within each cassette, there are six variable regions (VRs) that
display considerable sequence diversity, interspersed with six
relatively invariant regions (IRs). The structure of the VlsE
polypeptide is predominated by alpha helices that are believed to
be important in maintaining protein structure [12]. The variable
regions form random coils on the membrane distal surface of the
protein, the region most likely to be exposed to the host immune
system. VlsE variants have different epitopes when compared with
parental VlsE1 polypeptide [10,13], indicating that sequence
changes in vlsE result in true antigenic variation.
In the B. burgdorferi strain B31, the vls locus is located near the
telomere of the linear plasmid lp28-1 [10]. Loss of lp28-1 in B.
burgdorferi B31 is associated with an intermediate infectivity
phenotype in immunocompetent mice, in which infection lasts
for less than 3 weeks and is largely restricted to joint tissue
[14,15,16,17]. Spirochetes lacking lp28-1 are able to survive and
cause disease at all tissue sites in severe combined immunodefi-
ciency (SCID) mice [17,18], indicating that one or more gene
products encoded on lp28-1 play an important protective role
against adaptive immunity. Bankhead and Chaconas [19] recently
demonstrated that the vls locus is the important mediator of
infectivity in lp28-1. Deletion of the locus by telomere-mediated
truncation resulted in an intermediate infectivity phenotype
similar to that displayed by B. burgdorferi lacking lp28-1, while
deletion of the other end of the plasmid had no detectable effect on
infectivity.
The mechanisms that regulate vlsE recombination and expres-
sion are not well understood. vlsE recombination events have not
been detected in ticks, during in vitro culture, or in dialysis
membrane chambers embedded in rats, suggesting that non-
dialyzable host components play a role in initiation of recombi-
nation [20,21,22,23]. In contrast, vlsE recombination is detectable
within 4 days of mouse inoculation, and appears to occur
throughout the course of mammalian infection [22,24]. Approx-
imately 50% of recovered spirochetes have recombined vlsE
sequences during the first 7 days of mouse infection; by four weeks,
no organisms with parental vlsE sequence can be recovered
[11,22]. In immunodeficient SCID mice, spirochetes with the
parental vlsE disappear more gradually, indicating that the
adaptive immune response is required for the rapid elimination
of organisms expressing the parental VlsE [11]. Although analyses
of vlsE transcription levels during mammalian infection have
yielded variable results, immunoblot analysis indicates that VlsE
protein expression is dramatically upregulated during mouse or
rabbit infection [25,26].
Genes involved in DNA recombination and repair have been
found to play a role in antigenic variation in other bacteria. For
example, in Neisseria gonorrhoeae, pilin antigenic variation requires
several trans-acting factors in the RecF-like recombination
pathway, including RecA, RecX, RecJ, RecO, RecQ, and RecR
[27,28,29] as well as RecG and a functional RuvABC complex
[30]. However, in B. burgdorferi no genes have been yet identified
that play a role in recombination within vlsE, although recA has
been shown to be dispensable [31].
To identify proteins that play a role in vlsE recombination, we
screened transposon mutants of DNA recombination and repair
genes for infectivity and vlsE recombination. We found that
mutants in the genes encoding the Holliday junction helicase
polypeptides RuvA and RuvB were compromised in their ability to
undergo vlsE recombination and displayed a reduced infectivity
phenotype. In SCID mice, ruvA mutants retained full infectivity.
vlsE sequences recovered from SCID mice were identical to
parental vlsE sequence, suggesting that the failure to undergo vlsE
recombination was a critical factor in the reduced infectivity
phenotype. Furthermore, ruvA mutants had no increase in
sensitivity to DNA damage. Nearly identical results were obtained
in the accompanying article by Dresser et al. [32].
Results
Screening of putative DNA recombination and repair
mutants for infectivity and VlsE variation
For this study, 9 transposon insertion mutants representing 7
different genes whose homologues are known to be involved in
DNA recombination and repair in other bacteria were selected
from a large Signature Tagged Mutagenesis (STM) panel to screen
for their effect on infectivity and vlsE recombination (Table 1).
Independent mutants from two of the genes were included to test
the possible role of different insertion sites on infectivity and vlsE
recombination. T05P01C02 and T10P01D06 are independent
mutants of BB0797 with insertion ratios of 0.73 and 0.97
respectively. (The insertion ratio represents the relative position
of the transposon insertion in a coding sequence, with the entire
coding sequence having a value of 1.0). Likewise, T08P01E02 and
T11P01F09 are independent mutants from gene BBE29 with
insertion ratios of 0.33 and 0.30. Each mutant was injected in 5
mice and skin biopsies were taken at days 7 and 14 after
inoculation and cultured for B. burgdorferi. Mice were sacrificed on
day 28 of infection, and samples taken from skin, tibiotarsal joint,
heart, and bladder were cultured to recover infectious organisms.
B. burgdorferi maintained in in vitro culture sometimes lose plasmids
that are not required for in vitro growth but may be required for
infectivity. Therefore, the plasmid content of each mutant was
determined and compared with that of the parental clone
5A18NP1. Circular plasmid cp9 was found to be missing in two
mutants (T11P01A01 and T11P01F09) and lp21 is lacking in
T10P01D09. However, previous studies have shown that neither
cp9 nor lp21 are essential for infection of mice [14,15].
Author Summary
Lyme disease is the most prevalent tick-borne infection in
North America and Eurasia. It is caused by the bacterium
Borrelia burgdorferi and is transmitted to humans via the
bite of infected ticks. These spirochetes can cause both
acute and chronic infection and inflammation of the skin,
joints, heart, and central nervous system. The persistence
of infection despite the presence of an active immune
response is dependent upon antigenic variation of VlsE, a
35 kDa surface-exposed lipoprotein. A large number of
different VlsE variants are present in the host simulta-
neously and are generated by recombination of the vlsE
gene with adjacent vls silent cassettes. To try to identify
factors important in vlsE recombination and immune
evasion, we selected mutants in genes involved in DNA
recombination and repair and screened them for infectivity
and vlsE recombination. Mutants in genes encoding RuvA
and RuvB (which act together to promote the exchange of
strands between two different DNA molecules) had
reduced infectivity and greatly diminished vlsE recombi-
nation. In immunodeficient mice, ruvA mutants retained
full infectivity, and no vlsE recombination was detected.
Our findings reinforce the importance of vlsE variation in
immune evasion and persistent infection.
RuvAB and vlsE Recombination
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recovered from 29 of 30 tissue samples on days 7, 14, and 28 post
inoculation [33]. Three of the nine DNA repair mutants tested
(T11P01A01, T03TC051, and T05P01C02) exhibited reduced
infectivity and one (MG065) lost infectivity in immunocompetent
mice (Table 2). One of the mutS mutants (T05P01C02) displayed a
reduced infectivity phenotype, whereas the other mutant
(T10P01D06) had normal infectivity. The insertion site for the
highly infectious mutant was very close to the end of the coding
sequence (0.97), so this mutant may express a functional product.
ruvA (T11P01A01) and ruvB (T03TC051) mutants both exhibited
intermediate infectivity patterns. While 5/5 skin cultures were
positive for both mutants at day 7 post inoculation, by 2 weeks no
skin cultures were spirochete positive, and at 4 weeks only 6 of 20
and 10 of 16 tissue sites were culture positive for the ruvA and ruvB
mutants, respectively. We also examined the growth rates of the
ruvA and ruvB mutants in vitro. Both mutants had growth kinetics
very similar to that of the parental strain 5A18NP1 (data not
shown), indicating that the reduced infectivity phenotype observed
for the mutants was not due to a growth defect.
Restriction fragment length polymorphism (RFLP) was used to
estimate the extent of vlsE variation in recovered organisms.
Amplicons corresponding to the vlsE cassette region were
generated by PCR from uncloned cultures and digested with
Table 1. Transposon mutants utilized in this study.
Mutant Replicon
Insertion
Site
a
Insertion
Ratio
b Gene Predicted Product Infectivity
Results, RFLP Analysis
of vlsE recombination
T11P01A01 Chrm 22339 0.67 BB0023 junction DNA helicase, subunit A (RuvA) Reduced Reduced
T03TC051 Chrm 21916 0.18 BB0022 junction DNA helicase, subunit B (RuvB) Reduced Reduced
T05P01C02 Chrm 841133 0.73 BB0797 DNA mismatch repair protein (MutS) Reduced Reduced
T10P01D06 Chrm 841754 0.97 BB0797 DNA mismatch repair protein (MutS) Normal Normal
T10P01G11 Chrm 632960 0.24 BB0607 rep helicase, single-stranded
DNA-dependent ATPase (Rep)
Normal Normal
MG065 Chrm 96742 0.09 BB0098 recombination and DNA strand exchange
inhibitor protein (MutS-II)
Noninfectious ND
c
T08P01E02 lp25 20092 0.33 BBE29 adenine specific DNA methyltransferase,
authentic frameshift
Normal Normal
T11P01F09 lp25 20047 0.30 BBE29 adenine specific DNA methyltransferase,
authentic frameshift
Normal ND
T09P01G01 lp17 12892 0.88 BBD20 transposase-like protein, authentic frameshift Normal Normal
The plasmid content of the mutants was the same as that of the parent strain 5A18NP1 (lp28-4
2,l p 5 6
2) for all of the clones except for T11P01A01 and T11P01F09,
which were also cp9
2.
aCoordinates of transposon insertion in the indicated replicon. Chrm=chromosome.
bNumber of nucleotides(beginning of the open reading frame to the transposon insertion site)/Number of nucleotides(open reading frame).
cNot determined.
doi:10.1371/journal.ppat.1000679.t001
Table 2. Infectivity of B. burgdorferi DNA repair and recombination mutants in CH3/HeN mice at days 7, 14 and 28 post
inoculation.
Day 7 Day 14 Day 28
No. of cultures positive/total
No. of mice
positive/total
Strain Gene disrupted Gene Name Insertion Ratio Skin Skin Skin Joint Heart Bladder All sites
5A18NP1 (control) – – – 5/5 5/5 4/5 5/5 5/5 5/5 19/20 5/5
T11P01A01 BB0023 ruvA 0.67 5/5 0/5 2/5 2/5 1/5 1/5 6/20 3/5
T03TC051 BB0022 ruvB 0.18 4/4 0/4 3/4 3/4 2/4 2/4 10/16 3/4
T05P01C02 BB0797 mutS 0.73 1/5 1/5 1/5 1/5 1/5 1/5 4/20 1/5
T10P01D06 BB0797 mutS 0.97 5/5 5/5 4/5 5/5 5/5 5/5 19/20 5/5
T10P01G11 BB0607 rep 0.24 5/5 5/5 5/5 5/5 5/5 5/5 20/20 5/5
MG065 BB0098 mutS-II 0.09 0/5 0/5 0/5 0/5 0/5 0/5 0/20 0/5
T08P01E02 BBE29 --
a 0.33 5/5 5/5 5/5 5/5 5/5 5/5 20/20 5/5
T11P01F09 BBE29 --
a 0.30 5/5 5/5 5/5 5/5 5/5 5/5 20/20 5/5
T09P01G01 BBD20 --
b 0.88 5/5 5/5 3/5 5/5 5/5 5/5 18/20 5/5
Each of 4 or 5 mice per group were inoculated intradermally at the base of the tail with 10
5 of the indicated B. burgdorferi strain.
aadenine specific DNA methyltransferase, authentic frameshift.
btransposase-like protein, authentic frameshift.
doi:10.1371/journal.ppat.1000679.t002
RuvAB and vlsE Recombination
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occurs with varying frequency as a result of vlsE recombination.
The vlsE cassette region of 5A18NP1, the parental strain used in
this study, has a single HphI site near one end (Figure 1A). As
expected, cultures from mice inoculated with 5A18NP1 displayed
significant RFLP variability that increased over the course of
infection, as indicated by multiple bands or the presence of a
smear in the HphI-digested samples (Figure 1A). In contrast, the
ruvA and ruvB mutant cultures (Figure 1B and 1C) had vlsE RFLP
patterns that were either unchanged or had relatively few bands
without smearing, indicating that few vlsE variants had been
generated during the course of infection. The other putative DNA
recombination and repair mutants had complex vlsE RFLP
patterns, indicating that a variety of vlsE variants had been
generated during infection and that vlsE recombination likely had
occurred normally (data not shown).
Characterization of the ruvA mutant
ruvA and ruvB have been reported to be part of a larger operon
containing two additional genes (Figure S1A), queA (BB0021, S-
adenosylmethionine:tRNA ribosyltransferase-isomerase) and pfpB
(BB0020, diphosphate-fructose-6-phosphate 1-phosphotransferase)
[34]. To determine whether expression of other genes in the
operon might be disturbed by the transposon insertion, we
Figure 1. RFLP analysis of vlsE cassette region PCR products indicates reduced vlsE variation in ruvA and ruvB mutants of
B. burgdorferi. Representative results obtained following inoculation of C3H/HeN mice with (A) the parental clone 5A18NP1, (B) the transposon
mutant T11P01A01 (ruvA::himar1) and (C) T03TC051 (ruvB::himar1) are shown. Cultures from the indicated time points and tissues were used as the
source of template DNA for amplification of the vlsE cassette region. The resulting PCR products were either treated (+) or not treated (-) with the
restriction enzyme HphI. Presence of multiple bands or a smear in the HphI-treated sample is indicative of the presence of a high number of vlsE
variants. The day post inoculation is indicated by D4 through D28. Tissues examined include skin (S), bladder (B), heart (H) and tibiotarsal joint (J).
doi:10.1371/journal.ppat.1000679.g001
RuvAB and vlsE Recombination
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5A18NP1 and the ruvA mutant T11P01A01. Primer pair 1 generates
a PCR fragment from within the ruvA coding region that crosses the
transposon insertion site. As expected, this fragment can be generated
using RNAfrom the parental strain, but not using RNA from theruvA
mutant, or RNA untreated with reverse transcriptase (Figure S1B).
However, RT-PCR products spanning regions of both ruvB and queA
were generated from both strains using primer pair 3 and 4 (Figure
S1B). In the ruvA mutant T11P01A01, the transposon is inserted such
that a ‘read-through’ transcript could possibly be generated from the
flgBP::aacC1 cassette within the transposable element. To test that
possibility we used primer pair 2, which generates a PCR fragment
corresponding to the ruvA coding sequence downstream of the
transposon insertion site. A product could be generated from both
strains (Figure S1B), suggesting that ‘read-through’ may be occurring
from either the transposon or the native promoter. Thus, we
conclude that T11P01A01 is defective in expression of ruvA, but that
transcription of ruvB, queA and pfpB is occurring. However, we cannot
rule out the possibility of polar effects resulting from changes in the
levels of expression of ruvB, queA and pfpB.
Inactivation of ruvA results in reduced infectivity in
immunocompetent (C3H/HeN) mice but full infectivity in
immunodeficient (SCID) mice
To further examine the effects of ruvA disruption on infectivity
and vlsE recombination, a more detailed analysis of infectivity was
performed (Table 3). Groups of ten immunocompetent C3H/HeN
mice and ten C3H/scid mice were each inoculated with 10
5
organisms of either the T11P01A01 (the ruvA mutant), or the
parental clone 5A18NP1. Mice were also inoculated with the
previously characterized lp28-1
2 clone 5A8 [15] as a negative
control. Groups of 5 mice were sacrificed at days 14 and 28 post
inoculation. Samples of ear, tibiotarsal joint, heart, and bladder
were collected for recovery of spirochetes. As expected, the
positive control clone 5A18NP1 was fully infectious in both mice
strains; spirochetes were isolated from all sites at day 14 and day
28 post inoculation (Table 3). The lp28-1
2 clone 5A8 exhibited
the expected intermediate infectivity phenotype. In normal mice
inoculated with 5A8, spirochetes were recovered from only three
joint cultures at day 14, and no organisms could be recovered by
day 28 post inoculation. However, all tissue sites were infected in
C3H/scid mice inoculated with 5A8. The ruvA mutant exhibited an
infectivity phenotype similar to that of lp28-1
2 B. burgdorferi at day
14, but resulted in some positive cultures at day 28 post
inoculation (Table 3). In C3H/HeN mice infected with the ruvA
mutant, only 3 joint cultures of 20 possible cultures were positive
for spirochetes at day 14 post inoculation, whereas 20 of 20
cultures were positive in the C3H/scid mouse group. At day 28,
the ruvA mutant was recovered from 2/5 ear, 2/5 tibiotarsal joint,
2/5 heart, and 1/5 bladder cultures in immunocompetent mice,
while again all cultures were positive in the C3H/scid mouse
group. These results indicate that the ruvA mutant is significantly
impaired in infectivity compared to the parental strain; it is not,
however, as severely compromised as the strain lacking lp28-1.
RuvAB is not required for survival in ticks
We also tested the ability of B. burgdorferi carrying the ruvA or
ruvB mutation to survive in ticks. I. scapularis nymphs were
inoculated with the ruvA mutant T11P01A01, the ruvB mutant
T03TC051, or the parental strain 5A18NP1 by capillary feeding.
Ticks were held for 21–25 days and cultured for B. burgdorferi either
before or immediately after feeding on 3 C3H/HeN mice. B.
burgdorferi were readily detected in both fed and unfed ticks, as
determined by direct fluorescent antibody (DFA) staining and
culture (Table 4). This result indicates that the ruvA and ruvB
mutations do not abrogate the ability of B. burgdorferi to survive in
ticks. In addition, the mutant spirochetes were able to multiply
upon tick feeding (Table 4). Fewer spirochetes were recovered
from fed ticks carrying the ruvB mutant as compared to the ruvA
mutant or the parental strain, but enough spirochetes were present
in fed ticks to expect a mouse infection to result. However, tissues
collected 4 weeks post tick inoculation with the ruvA or ruvB
mutants were consistently culture negative (Table 4). The failure to
recover organisms from any cultures derived from tick-inoculated
mice (as compared to the sporadically positive cultures from
needle-inoculated animals; Table 2) may be due to the lower
number of organisms delivered during tick inoculation as
compared to needle inoculation, coupled with the decreased
survival of ruvA or ruvB mutants in immunocompetent mice at 28
days post inoculation (Table 2).
Inactivation of ruvA or ruvB results in reduced vlsE
recombination
Spirochetes recovered from infected mice were isolated by
colony formation, and the vlsE cassette region sequences of the
resulting clones were determined by PCR amplification and
Table 3. Infectivity phenotype of the ruvA mutant T11P01A01 in immunocompetent C3H/HeN and immunodeficient C3H/scid
mice is similar to that of the lp28-1
2 clone 5A8.
Day14 Day28
No. of cultures positive/total
No. of mice
positive/total No. of cultures positive/total
No. of mice
positive/total
Mouse
strain
B. burgdorferi
B31 clone Skin Joint Heart Bladder All sites Skin Joint Heart Bladder All sites
C3H/HeN 5A18NP1 5/5 5/5 5/5 5/5 20/20 5/5 5/5 5/5 5/5 5/5 20/20 5/5
C3H/HeN ruvA mutant 0/5 3/5 0/5 0/5 3/20 3/5 2/5 2/5 2/5 1/5 7/20 3/5
C3H/HeN 5A8 0/5 3/5 0/5 0/5 3/20 3/5 0/5 0/5 0/5 0/5 0/20 0/5
C3H/scid 5A18NP1 5/5 5/5 5/5 5/5 20/20 5/5 5/5 5/5 5/5 5/5 20/20 5/5
C3H/scid ruvA mutant 5/5 5/5 5/5 5/5 20/20 5/5 5/5 5/5 5/5 5/5 20/20 5/5
C3H/scid 5A8 5/5 5/5 5/5 5/5 20/20 5/5 5/5 5/5 5/5 5/5 20/20 5/5
doi:10.1371/journal.ppat.1000679.t003
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recombination. For the ruvA mutant T11P01A01, a total of 382
vlsE sequences were analyzed, comprising sequences from both
immunocompetent and SCID mice, at three time points and from
four tissues. For the ruvB mutant T03TC051, a total of 62 clones
isolated from C3H/HeN mice were sequenced, including 22
obtained from skin cultures 7 days post inoculation, and 40 clones
from joint, heart, bladder and skin cultures 28 days after
inoculation.
The overall pattern of vlsE recombination observed is depicted
in Figure 2. For each mouse group and time point, it was
determined whether the recovered clones retained the parental
vlsE sequence, had a unique vlsE sequence, or shared the same vlsE
variant sequence when compared to other clones from the same
animal (‘vlsE sequences with siblings’). It has been determined
previously that vlsE variation is not detectable during in vitro
culture [22]; therefore all inoculated organisms initially contained
the parental vlsE sequence.
As observed in prior studies with B. burgdorferi B31 clones, the
parental strain 5A18NP1 underwent rapid vlsE recombination in
both C3H/HeN and C3H/scid mouse hosts. By 14 days post
inoculation, 0/59 clones from C3H/HeN mice had retained the
Table 4. B. burgdorferi ruvA and ruvB mutants survive well in ticks, but do not establish long-term infection in mice following tick-
mediated inoculation.
B. burgdorferi Strain Unfed Ticks Fed Ticks
Mouse
Tissues
Positive
Cultures
Mean no. of spirochetes
per field6SD
p value
(Mutant vs. WT)
Positive
Cultures
Mean no. of spirochetes
per field6SD
p value
(Mutant vs. WT)
Positive
Cultures
ruvA mutant 9/10 0.9360.42 0.77 24/24 27.3616.2 0.841 0/12
ruvB mutant 9/10 1.4160.44 0.17 24/25 12. 467.6 0.053 0/12
5A18NP1 8/10 1.0660.33 26/26 24.4624.1 12/12
I. scapularis nymphs were inoculated with the ruvA mutant T11P01A01, the ruvB mutant T03TC051, or the parental strain 5A18NP1 by capillary feeding, as described in
Materials and Methods. Ticks were held for 21–25 days and cultured for B. burgdorferi either before or immediately after feeding on 3 C3H/HeN mice. The mice used for
feeding were euthanized 4 weeks afterwards, and heart, bladder, ear, and tibiotarsal joint tissue specimens were utilized for B. burgdorferi culture. Spirochetes were
quantified by direct immunofluorescence either in flat or fed ticks. One half of each tick was used for culture and the other half for immunofluorescence. Statistical
significance (p,0.05) was assessed by ANOVA.
doi:10.1371/journal.ppat.1000679.t004
Figure 2. vlsE sequence variation observed with the parental strain 5A18NP1 and the ruvA mutant T11P01A01 and the ruvB mutant
T03TC051 following inoculation of immunocompetent C3H/HeN mice and immunodeficient C3H/scid mice. The combined results from
all tissues examined for each time point are shown. The vlsE cassette regions of individual B. burgdorferi clones were amplified by PCR, sequenced,
and characterized as either identical to the parental vlsE sequence, a unique vlsE sequence for that mouse, or two or more clones with an identical
vlsE variant sequence from a mouse (vlsE sequences with siblings).
doi:10.1371/journal.ppat.1000679.g002
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sequences predominated after 7 days, although a surprisingly
high proportion of sibling variants was observed in C3H/HeN
mice inoculated with 5A18NP1 (Figure 2, Table S1). At 14 and 28
days post inoculation, no clones with the parental vlsE sequence
were detected. A similar pattern was observed during infection of
C3H/scid mice, although the dilution of parental sequence clones
occurred at a slower rate; 19/76 clones (25%) still had the parental
sequence on day 14. However, even in C3H/scid mice no clones
with the parental vlsE sequence were recovered at day 28 post
inoculation.
In contrast, sequence analysis demonstrated that very little vlsE
sequence variation occurred during infection of mice with the ruvA
mutant T11P01A11 (Figure 2, Table S1). In immunocompetent
mice, only clones with the parental sequence were recovered up to
14 days post inoculation. By day 28 very few (3 of 114, 3%) of the
clones retained the parental sequence; however, the remaining
clones were quite restricted in terms of sequence variation, with
each animal possessing only 1 or 2 variant types. Surprisingly, only
parental sequence clones were recovered from C3H/scid mice on
days 14 and 28 post inoculation, indicating that clones that had
not undergone vlsE variation predominated in the absence of
immune selection. The ruvB mutant T03TC051 also exhibited
reduced vlsE sequence variation during infection of C3H/HeN
mice (Figure 2, Table S1).
The differences between sequence variation in 5A18NP1 and
T11P01A01 are further illustrated in Figure 3. Sequence diversity
among the clones isolated at day 28 post inoculation from C3H/
HeN mice was analyzed using phylogenetic tree software. The 63
clones from infection with 5A18NP1 were from joint, heart,
bladder, and ear tissues of a single mouse, whereas the 114 clones
for T11P01A01 were from the 12 culture-positive samples from 6
different mice. With clone 5A18NP1, 31/63 (49%) of the clones
characterized possessed unique vlsE sequences; the remaining
clones were variant siblings that were isolated from the same
mouse tissue. Moreover, closely related sequences were often
isolated from the same tissue (Figure 3A, brackets), indicating that
vlsE sequences in sibling clones were diverging within those tissues.
For the ruvA mutant T11P01A11, only eight different vlsE
sequences could be detected among the 114 clones examined in
the 6 mice, and no more than two different sequences were found
in any one animal (Figure 3B). Moreover, clones with the same
sequence were often found in more than one tissue site (Figure 3B,
brackets). Three clones that retained the parental vlsE sequence
were also isolated. These results provide further evidence that the
ruvA mutant is severely compromised in its ability to undergo vlsE
recombination.
The sequences of 17 bp direct repeats at the 59 and 39 ends of
vlsE central cassette were examined in all of the vlsE sequences
recovered from ruvA mutants. No changes were identified
indicating that vlsE recombination was not perturbed in the ruvA
mutants due to instability of the direct repeats during mouse
infection and/or vlsE recombination.
In E. coli and other organisms, ruvA and ruvB act in concert to
promote DNA branch migration. Therefore, we also examined the
effects of ruvB mutation on vlsE sequence variation in C3H/HeN
mice. As shown in Figures 2 and S3 and in Table S1, the ruvB
mutant T03TC051 exhibited reduced vlsE recombination rates
similar to those observed for the ruvA mutant. No vlsE variants
were observed at 7 days post inoculation. On day 28, the vlsE
cassette region sequences of 12 to 14 clones from each of three
mice were determined. Each animal was found to have only 1 to 3
vlsE variant sequences, and 5 clones with the parental vlsE
sequence were isolated from Animal 3 (Figure S3). Only one clone
with a unique vlsE variant sequence was identified (1/40, 2.5%).
There were subsets of clones with the same vlsE variant sequence,
consistent with the outgrowth of siblings of rare vlsE variants
(Figures 2 and S3). Thus the ruvB mutant T03TC051 had an
infectivity and vlsE variation phenotype that was quite similar to
that observed for the ruvA mutant T11P01A01.
Analysis of vlsE recombination events in the ruvA and
ruvB mutants
The non-parental vlsE variants recovered 28 days post infection
with the ruvA and ruvB mutants were analyzed to determine the
length, location and silent cassette source of the recombination
events (Figure 4, Figure S2). Each sequence was aligned with
parental vlsE sequence, codon formatted and analyzed using a
semi-automated analysis program [11]. The program compares
each codon to parental and silent vls sequences and depicts the
result (identity or no identity) as colored bars with each silent
cassette assigned a unique color. Dark regions represent the
sequence changes that may have resulted by recombination with
that silent cassette. The lighter colored regions are contiguous
codons that match both parental and silent cassette sequences and
thus represent the possible boundaries of a recombination event.
The most likely recombination events are presented in Figure 4;
a more detailed presentation showing all silent cassettes potentially
involved in the recombination events is shown in Figure S2.
Variants recovered from infections with 5A18NP1 at day 28 of
infection are usually difficult to assign to a single silent cassette
with confidence and appear to have undergone multiple
recombination events ([4] and data not shown). For example,
the simplest explanation for the variant recovered from a mouse
infected with 5A18NP1 (Figure 4, first panel) appears to involve
multiple recombinations of varied lengths with 6 different silent
cassettes. In contrast, the results obtained with the ruvA and ruvB
mutants were consistent with the occurrence of relatively rare and
elongated vlsE recombination events (Figure 4). This pattern is
exemplified by the vlsE sequence recovered from animal 1, which
likely represents a single recombination event with vls5 spanning
almost the entire cassette region. Although many silent cassettes
have sequence identity to the variant residues, vls5 represents the
only continuous match over the entire region (Figure S2). One
variant (animal 2) is predicted to have undergone untemplated
changes (not matching any vlsE silent cassette) in VR-I followed by
an intermittent recombination event with vls2. Several of the
recombination events found in the ruvA mutant appear to be
intermittent, i.e. the recombination events were discontinuous over
the length of the cassette, alternating between the template cassette
and vlsE1. This intermittent recombination has been previously
observed in vlsE recombination [11]. In addition, we noted that all
recombination events from ruvA mutants included variable regions
IV through VI. This bias is not observed with the parental strain
[4]. Equally striking is length of the recombination events observed
in the ruvA mutant. Coutte et al. [11] analyzed 126 clones that had
undergone a single recombination event and identified the
minimum and maximum predicted lengths of recombination.
The majority of these clones (55%) had minimum recombination
lengths of 1–5 nucleotides and only 28% had minimum
recombination lengths of .15 nucleotides. The variants obtained
from ruvA mutant infections, however, had a median minimum
recombination length of 168 bp (range 91 to 479 bp), and a
median maximum recombination length of 269 bp (range 111 to
546 bp).
Another unusual feature of the recombination events seen in the
ruvA mutant is the distribution of silent cassette usage. Only 3 silent
cassettes, vls2, vls4, and vls5 were used in the seven templated
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Clones were isolated from C3H/HeN mice 28 days post inoculation with (A) the parental strain 5A18NP1 or (B) T11P01A01. The vlsE cassette region
sequences of each clone were optimally aligned and then analyzed for sequence diversity using a phylogenetic tree program. The 5A18NP1 clones
were isolated from a single mouse, whereas the T11P01A01 clones were obtained from all positive cultures of 6 inoculated mice. The groups of clones
isolated from each mouse and their tissue source are indicated. In (A), brackets demarcate clusters of related (but often nonidentical) clones that
occurred in the mouse infected with 5A18NP1. In the 5A18NP1 group, there were 31 unique vlsE sequences, 10 sequences with siblings, and 0
parental sequences. In (B), brackets indicate clones with identical vlsE sequences that were isolated from the 6 mice, frequently from multiple tissues.
In this group of clones from mice inoculated with the ruvA mutant, there were 0 unique sequences, 8 sequences with many siblings, and 3 parental
sequences. Trees are rooted with the 5A18NP1 parental vlsE sequence. A larger version of this figure is available at the website http://www.uth.tmc.
edu/pathology/borrelia/.
doi:10.1371/journal.ppat.1000679.g003
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most proximal to the expression cassette has been observed to be
used very rarely in infections with wild type B. burgdorferi, yet we
observed it in three of seven templated ruvA variants. These results
suggest that the normal mechanism of silent template selection
may be perturbed in ruvA mutants.
Figure 4. Low complexity of vlsE recombination events in ruvA and ruvB mutants. The positions of the six variable regions (VR1–VR6) and
six relatively invariant regions (IR1–IR6) within the vlsE central cassette region are provided at the top of the figure. The locations and silent cassette
sources of the most likely recombination events for each clone depicted are indicated. A representative clone from a 28 day infection with the
parental strain 5A18NP1 is shown at the top. The remainder of the figure shows the vlsE variant clonotypes isolated from C3H/HeN mice 28 days post
inoculation with the ruvA mutant T11P01A01 or the ruvB mutant T03TC051. The possible involvement of each of the silent cassettes in sequence
variation was analyzed using an ExcelH/Visual Basic program, as described previously [11] and depicted in Fig. S2. The horizontal colored bars
represent regions of each silent cassette (vls2 to vls16, top to bottom) that match the sequence changes found in the variant clone. Dark regions in
each bar correspond to the actual sequence changes, whereas the lighter portion of the bar represents the maximum possible region of that silent
cassette exchanged into vlsE to produce the observed sequence change. In isolates from Animal 2 inoculated with the ruvA mutant, a 9 bp
untemplated change (black hatched box) that did not match the vls silent cassettes or any other genomic sequence was present in all clones isolated.
doi:10.1371/journal.ppat.1000679.g004
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displayed similar features to those from the ruvA mutant (Figures 4
and S2). Most sequences were the result of single recombination
events and used few vls silent cassette templates. The recombina-
tions observed were unusually long, with a median minimum
recombination length of 151 bp (range 119 to 389 bp) and an
average maximum length of 179 bp (range 151 to 561 bp).
Recombination events always included most of the 39 end of the
recombination cassette; however, these recombinations did not
always include VR6, as observed for the recombination events
derived from ruvA mutants.
Antibody responses to vlsE in ruvA and ruvB mutants
To determine whether mice infected with the ruvA and ruvB
mutants developed a robust antibody response to VlsE, we
performed ELISAs on serum from infected animals. We found
that serum from animals infected with the ruvA or ruvB mutants
displayed more variable antibody responses to VlsE than animals
infected with the parental B. burgdorferi strain (data not shown).
Some animals displayed similar reactivity to sera from animals
infected with parental strain while others displayed lower anti-
VlsE activity. However, low anti-VlsE titers did not necessarily
correlate with positive B. burgdorferi cultures from harvested organs.
It is speculated that low quantities of anti-VlsE antibodies in some
mice may correspond to early clearance of B. burgdorferi, thus
resulting in a limited stimulation of the immune response against
Borrelia antigens, including VlsE.
Attempted complementation of the ruvA mutant
In an attempt to fully demonstrate the role of ruvA in vlsE
sequence variation and infectivity, we complemented the ruvA
mutant T11P01A01 with the shuttle vector pKFSS1 [35]
containing either ruvA alone, ruvAruvB,o rruvAruvBqueApfpB
(the four genes in the predicted operon; Figure S1). A 264-bp
region upstream of ruvA predicted to include the transcriptional
promoter was included in all three constructs. The integrity of
the resulting plasmids was confirmed by sequencing the inserts,
and transformation of T11P01A01 was demonstrated by
streptomycin selection followed by PCR using one primer
specific for the pKFSS1 vector sequence and one primer
corresponding to the B. burgdorferi DNA insert. Groups of three
mice were each inoculated intradermally (10
5 organisms/mouse)
with one of two clones containing each complementation
construct, yielding 366=18 mice inoculated with complement-
ed lones. The two control groups (3 mice each) were inoculated
with positive control 5A18NP1 and the non-complemented ruvA
mutant T11P01A01. All strains yielded positive cultures from
each of 3 skin sites taken distant from the inoculation site on day
7, indicating that the infection was successful in each case. Six
representative day 7 cultures were tested for the presence of the
complementing plasmids by PCR, and yielded the expected
amplicons. All cultures except those from 5A18NP1-inoculated
mice were negative on day 14 post inoculation, and on day 28
the proportions of positive clones for the complemented clones
were similar to that obtained for the ruvA mutant T11P01A01
(data not shown). In addition, 17 complemented clones isolated
on day 7 post inoculation were examined for vlsE recombination,
and none exhibited vlsE sequence changes; this result was similar
to what had been observed previously with uncomplemented
ruvA mutant clones at this time point (Figure 2, Table S1).
Therefore attempts to restore infectivity and vlsE sequence
variation to wild type levels by complementation have thus far
been unsuccessful.
Inactivation of ruvA does not result in increased
sensitivity to DNA damage
In many microorganisms, ruvA is important in the repair of
DNA damage resulting from UV irradiation or chemical
mutagens. To assess the role of B. burgdorferi ruvA in DNA repair
we monitored the survival of the ruvA mutant T11P01A01
subjected to DNA damaging conditions. Log phase cultures were
irradiated with increasing doses of UV (254nm) light, and cultured
to determine spirochete survival by colony counting. Figure 5A
shows the results of a representative experiment. The parental
strain 5A18NP1, and ruvA mutants had a similar number of
colonies surviving at all UV doses, indicating that ruvA mutants do
not have increased sensitivity to UV irradiation.
Mitomycin C causes DNA damage by crosslinking complemen-
tary DNA strands at CpG sequences and is a commonly used
reagent to examine the cellular response to DNA damage. To
determine the sensitivity of the ruvA mutants to mitomycin C we
assessed the viability of the ruvA mutant T11P01A11 and the
parental strain 5A18NP1 after 14 hours exposure to increasing
doses of mitomycin C. Treated cultures were plated and the
number of colonies visible after 2–3 weeks incubation was used
to assess spirochete survival. Figure 5B shows the survival of
Figure 5. The ruvA mutant T11P01A01 does not exhibit
enhanced sensitivity to UV light or mitomycin C. (A) Survival of
ruvA mutant and parental strain 5A18NP1 after exposure of UV light.
The dosages of UV irradiation (254 nm) applied to the bacterial
suspensions are indicated. (B) Survival of ruvA mutant and parental
strain 5A18NP1 after 14 h treatment with the indicated doses of
mitomycin C in BSK II medium. Colony counts on duplicate or triplicate
plates were utilized to determine the concentration of surviving B.
burgdorferi. Results shown are for representative experiments from
three independent studies for each treatment.
doi:10.1371/journal.ppat.1000679.g005
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mitomycin C. We observed no differences in survival between the
ruvA mutant and the parental strain 5A18NP1.
Discussion
We conducted a genetic screen for trans-acting factors involved
in vlsE antigenic variation in B. burgdorferi. Of the seven genes
examined in this screen, four exhibited diverse PCR-RFLP
patterns of vlsE, indicating that the inactivated genes are not
centrally involved in vlsE recombination in C3H/HeN mice.
Mutant MG065 in BB0098 (annotated as a recombination and
DNA strand exchange inhibitor and as mutS-II in other organisms)
was not recovered from inoculated mice, and thus could not be
evaluated for vlsE variation. Two of the remaining transposon
mutants, which had disruptions in the B. burgdorferi orthologs of the
Holliday junction helicase genes ruvA and ruvB, had reduced vlsE
recombination. The only other mutant that exhibited reduced
infectivity and PCR-RFLP diversity was a mutS mutant,
T05P01C02. A second mutS mutant, T10P01D06, had an
insertion site near the end of the gene (insertion ratio 0.97); this
clone had normal infectivity and RFLP results, indicating that a
functional product is likely produced. The possible role of mutS in
vlsE recombination will be investigated further in a separate study.
The predicted proteins encoded by the B. burgdorferi BB0023 and
BB0022 open reading frames have a high degree of homology with
the Holliday junction helicase proteins RuvA and RuvB,
respectively, of other organisms. In Escherichia coli, the 22-kDa
protein RuvA specifically targets RuvB to the Holliday junctions
[36,37], and the combined action of RuvAB results in branch
migration during homologous recombination [38]. The 19-kDa
RuvC resolvase cleaves the Holliday junction and is required for
resolution of Holliday junctions in E. coli [39]. No homolog of
RuvC has been identified in Lyme disease Borrelia, although RuvC
orthologs have been identified in other spirochetes including the
relapsing fever organism B. turicatae, T. pallidum, T. denticola and
L. interrogans. Aravind et al. has proposed that a family of predicted
LE exonucleases may substitute for RuvC in B. burgdorferi [40]. In
addition to their role in recombination, E.coli ruv mutants exhibit
defects in DNA repair such as increased sensitivity to UV light and
mitomycin C [41,42].
The infectivity phenotypes of the ruvA mutant T11P01A01 and
the ruvB mutant T03TC051 resemble those of B. burgdorferi strains
that lack lp28-1 [14,15,17,18] or the vls locus [19], although some
differences exist. As shown in Tables 2 and 3, the ruvA and ruvB
mutants exhibited lower culture positivity than the parental strain
5A18NP1 in immunocompetent C3H/HeN mice. The ruvA
mutant culture positivity pattern was the same as the lp28-1
2
clone 5A8 on day 14 post inoculation in C3H/HeN mice, with
only joint specimens yielding positive cultures (Table 3); however,
7/20 cultures in diverse tissues were positive for the ruvA mutant at
day 28 post inoculation, as compared to a lack of positive cultures
in the 5A8-inoculated animals. The ability of some ruvA
2
organisms to survive is most likely due to the ability to express
VlsE and to undergo limited vlsE recombination. The ruvA mutant
and the lp28-1
2 clone 5A8 is able to infect all tissues in C3H/scid
mice, as has been observed previously with lp28-1
2 strains and
clones in which the vls locus was deleted from lp28-1 by telomere-
mediated plasmid truncation [19]. Thus mutation of ruvA results in
reduced ability to survive in the presence of the adaptive immune
system, perhaps due to antibody responses against invariant or
limited variation forms of VlsE.
We also tested the ability of B. burgdorferi carrying ruvA or ruvB
mutations to survive in ticks. B. burgdorferi were readily recovered
from both fed and unfed ticks suggesting that the ruvA and ruvB
mutations do not abrogate the ability of B. burgdorferi to survive in
ticks. However, the mutant spirochetes did not establish infection
in C3H/HeN mice following tick inoculation (Table 4). These
data suggest that the lack of detectable organisms at day 28 post
mouse inoculation (Table 4) was due to the effects of ruvA and ruvB
mutations on survival in mice rather than poor replication in ticks
or transmission from ticks to mammals. The failure to recover
organisms in cultures derived from mouse inoculation via ticks
may be due to the relatively low number of organisms delivered
during tick inoculation as compared to the 10
5 Borrelia per mouse
used in the needle inoculation studies.
The reduced ability of the ruvA mutant T11P01A01 to undergo
vlsE recombination is illustrated in Figures 3, 4, and S3. Figure 3
shows that vlsE variants were not detected on days 7 and 14 in
C3H/HeN mice inoculated with the ruvA mutant; while vlsE
variants are predominant on day 28, only one or two variant
clones are detected in each mouse (Figures 4 and 5). Remarkably,
no vlsE variants were detected at any time point following infection
of C3H/scid mice with the ruvA mutant, whereas all of the clones
examined at 28 days post inoculation were variants when C3H/
scid mice were inoculated with the parental 5A18NP1 strain.
Combining the reduced culture positivity results with the
decreased vlsE variant diversity observed with the ruvA mutant,
the following is evident: 1) inactivation of ruvA results in reduction
of vlsE recombination rates, resulting in only a few variants in
C3H/HeN mice and the lack of detected variants in C3H/scid
mice; and 2) in C3H/HeN mice, the few clones that have
undergone vlsE recombination are able to survive after the anti-
VlsE response is activated, whereas nearly all of the parental
clones are eliminated by day 28 post inoculation.
The types of recombination events observed in the ruvA mutant
were also quite different than those observed in wild-type B.
burgdorferi. The average length of observed recombination events
was an order of magnitude larger than in wild type clones.
Moreover, most of the predicted recombination events observed in
the ruvA mutant also appeared to represent intermittent recom-
bination events, with regions of recombination interrupted by
stretches of the unchanged, parental vlsE sequence (Figure 5).
Finally, vls2, vls4, and vls5 were the only silent cassettes utilized in
the ruvA mutant. The ruvB mutant also exhibited a limited
repertoire of silent cassette usage (cassettes 2, 3, 4, 5, and 8). Taken
together, these results may indicate that the recombination process
is different in the ruvA mutant than in wild-type organisms; i.e., the
observed changes could involve a different, underlying recombi-
nation mechanism other than the as yet cryptic, vlsE-specific
process that appears to be induced during mammalian infection.
We found that sensitivity of B. burgdorferi to UV radiation and
mitomycin C exposure was not affected by ruvA mutation. In other
bacteria such as E. coli, deficiencies in RuvA, RuvB, or RuvC
result in increased sensitivity to DNA-damaging agents, including
UV irradiation and mitomycin C [43]. UV irradiation causes
intra-strand thymine dimers in DNA, and the damage is repaired
by RecA-mediated SOS response [44]. Mitomycin C exposure
induces inter-strand cross-link in DNA, and an extended SOS
response is needed to repair the damaged DNA [45]. Induction of
genes encoding DNA repair enzymes during the SOS response is
one of the most important DNA repair system in bacteria [46].
However, the B. burgdorferi genome does not encode a homolog of
the SOS response repressor LexA, and SOS boxes (LexA binding
sites in promoter regions) are not present upstream of recA and
other genes that comprise the SOS regulon [47]. Also, expression
of recA is not induced following UV exposure [48]. Thus B.
burgdorferi appears to lack an SOS regulon. As an obligate parasite,
RuvAB and vlsE Recombination
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have lost its ability to upregulate genes involved in the repair of
DNA damage caused by radiation and other agents.
Thus far, our attempts to restore full infectivity and vlsE
recombination through complementation with ruvA in the shuttle
vector pKFSS1 have been unsuccessful. In addition, we have also
tried using constructs containing ruvAruvB and ruvAruvBqueApfpB,i n
case the transposon insertion in ruvA has some polar effect on the
expression of downstream genes. A 264-bp region upstream of
ruvA was used in all of these constructs; it is presumed to contain
the promoter, although the region lacks a strong consensus
promoter sequence (e.g. 235 and 210 sequences with the proper
spacing). BB0024, the gene upstream of ruvA, is oriented in the
opposite direction, indicating that ruvA is the first gene in the
operon. Dresser et al. [49] have also been unsuccessful in trans
complementing ruvA and ruvB mutants obtained by allelic
exchange. The ruvA and ruvB mutants obtained by our laboratory
and by Dresser et al. [49] were derived independently by different
means (transposon mutagenesis and gene disruption by allelic
exchange), yet have nearly identical phenotypes. Thus it is likely
that the lack of complementation observed in these studies is due
to technical complications, as has been commonly observed in
genetic studies involving infectious B. burgdorferi. We will continue
our efforts to complement the ruvA and ruvB mutants in an attempt
to fulfill the ‘molecular Koch’s postulates’ on the roles of these
genes in infectivity in immunocompetent mice and in vlsE
recombination.
The current study along with those by Liveris et al. [31] and
Dresser et al. [32] provide some insight into the mechanism of
recombination in the vls antigenic variation system. The central
role of RuvAB indicates that heteroduplex formation with branch
migration is important in this process. The lack of a requirement
for RecA [31,32] is surprising. RecA provides two important
functions in other microorganisms: ATP-dependent formation of
RecA-single-stranded DNA nucleoprotein filaments that facilitate
the homologous base pairing during heteroduplex formation [50];
and cleavage of LexA to activate the SOS response through its
activity as a co-protease when bound to single-stranded DNA. As
indicated above, B. burgdorferi lacks a recognizable LexA ortholog,
so the latter function is likely to be unimportant (although co-
protease activity is present in B. burgdorferi RecA). Liveris et al. [31]
state that the apparent lack of effect of recA mutation on vlsE
recombination indicates that homologous recombination mecha-
nisms are not involved in this process. However, ‘templated’ vlsE
sequence changes (those involving incorporation of silent cassette
sequences) consistently occur at the same position as the optimal
alignment between the silent cassette and vlsE; i.e., the observed vls
silent cassette/vlsE recombinations are always homologous, and
never nonhomologous [11]. vlsE recombination is induced during
mammalian infection; it is possible that factor(s) that bind
specifically to vls sequences and promote strand invasion and
heteroduplex formation may be expressed under these conditions
and hence fulfill a RecA-like (but site-specific) role. Such factor(s)
have not been identified to date. Once a heteroduplex is formed,
RuvAB may promote the migration of the heteroduplex branch
point, thus extending the region of strand exchange. In a set of 126
vlsE variants that appeared to contain a single recombination event
[11], the putative minimal recombination events ranged from 1 nt
to 349 nt, with a median value of less than 5 nt. This result
indicates that the strand replacement process is often interrupted
quite soon after its initiation. The observed range of sequence
identity between donor and recipient sequences flanking the
region of sequence change was from 0 nt to 88 nt, with
(remarkably) as little as 6 nt on one side or the other [11]. It is
currently unknown whether the role of the RuvAB migrase is to
promote heteroduplex formation in these regions of sequence
identity (thus nucleating the strand exchange event), or whether it
is also able to ‘drive’ the strand pairing through regions of
sequence differences.
Gene conversion has been described as the predominant
mechanism in other bacterial and protozoal antigenic variation
systems, including those of relapsing fever Borrelia (e.g. B. hermsii),
Neisseria gonorrhoeae, Anaplasma marginale, Trypanosoma cruzi, and
Babesia bovis [51,52,53,54]. Lyme disease and relapsing fever
Borrelia are closely related, and VlsE and the variable large protein
(Vlp) antigenic variation proteins have some sequence similarity.
However, in B. hermsii the gene conversion events result from
homologous recombination within well-demarcated upstream
homology sequences (UHS) and downstream homology sequences
(DHS), resulting in replacement of nearly the entire expression site
gene with a silent gene sequence [53,55]; therefore it is different
from the vls system both in terms of mechanism and gene
conversion outcome. The N. gonorrhoeae pilE system, the A. marginale
MSP2, and the B. bovis VESA1a systems each involve segmental
gene conversion events utilizing multiple silent gene copies to
produce highly variable pilin or surface protein sequences. The
pilE system is dependent upon RecA and other recombination
system proteins that are not required for vlsE recombination, as
described in detail by Dresser et al. [32]. In A. marginale, the gene
conversion event is almost always ‘anchored’ in a conserved region
flanking the hypervariable region [56]. The mechanisms of B. bovis
VESA1a recombination are not well characterized, but are likely
to involve eukaryote-specific elements that will differ considerably
from those present in the prokaryote B. burgdorferi. Thus, based on
current knowledge, the vls system may represent a unique gene
conversion process that is mechanistically dissimilar to other
known antigenic variation systems.
Materials and Methods
Ethics statement
All procedures involving mice conducted at the University of
Texas Health Science Center at Houston were reviewed and
approved by the Animal Welfare Committee of that institution. All
mouse studies conducted at the Tulane National Primate Research
Center were reviewed and approved by its Institutional Animal
Care and Use Committee (IACUC).
Bacterial strains and growth medium
The transformable, infectious Borrelia burgdorferi B31 clone
5A18NP1 was used for generation of all mutants. 5A18NP1 is a
genetically modified clone in which plasmids lp28-4 and lp56 are
missing and BBE02, encoding a putative restriction-modification
enzyme, has been disrupted [33]. Borrelia burgdorferi B31 clone 5A8,
containing all plasmids except lp28-1, was isolated previously from
the low-passage strain B31 [15,57] and was used as negative
control in mouse inoculation experiments. All strains used in this
study had undergone no more than two subcultures since clone
isolation prior to infectivity studies. B. burgdorferi were grown at
34uCi n3 %C O 2 in Barbour-Stoenner-Kelly II (BSK-II) medium
supplemented with appropriate antibiotics as described previously
[58]. The in vitro growth rates of the ruvA and ruvB mutants and
the parental strain 5A18 NP1 were determined by daily
quantitation of organisms in triplicate cultures by dark-field
microscopy. E. coli TOP10, a DH5a
TM-derived strain obtained
from Invitrogen Corporation (Carlsbad, CA, USA), was used for
the preparation of plasmids for electroporation into B. burgdorferi.
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Genes putatively involved DNA recombination and repair were
inactivated by transposon mediated mutagenesis as part of a
transposon signature tagged mutagenesis (STM) study on-going in
the laboratory. This study will be described in detail in another
publication (Lin, T., L. Gao, C. Zhang, E. Odeh, and Norris, S.J.,
manuscript in preparation). Briefly, twelve independent mutant
libraries, each having a unique 7 bp sequence tag, were created
using modified versions of the suicide plasmid pMarGentKan.
This plasmid was graciously provided by Dr. P. E. Stewart (Rocky
Mountain Laboratories, National Institutes of Health, Hamilton,
MN) and is a modified version of pMarGent [59] in which a
kanamycin resistance cassette (flaB::aph1) was inserted in the
‘backbone’ of the vector, outside the himar1-based transposable
element and a flgB:aacC1 gene is inserted within the transposable
element (P. E. Stewart, unpublished data). After insertion of
unique sequence tags into pMarGentKan, 5 mg of each plasmid
was electroporated into B. burgdorferi B31 using a modification of
previously described methods [59,60]. The transformants were
incubated in BSK-II medium without antibiotics for recovery
overnight hours and plated in solid BSK-II media with 200 mg/ml
of kanamycin and 40 mg/ml of gentamicin as described previously
[57]. Colonies were selected and cultured in liquid BSK-II
medium until mid-log phase prior to addition of 15% (v/v)
glycerol and storage at 270uC. The transposon insertion site was
determined by restriction digestion of the Borrelia genomic DNA,
plasmid rescue in E. coli, and sequencing as described previously
[59]. Properties of the transposon mutants selected for this study
are shown in Table 1.
Determination of plasmid content
The plasmid profiles of DNA recombination and repair mutants
were determined by a microtiter plate-based PCR method as
previously described [15] or by a multiplex PCR scheme followed
by detection using LuminexH FlexMAP
TM technology. The
LuminexH procedure will be described in detail in another article
(S. J. Norris, J. K. Howell, E. Odeh, T. Lin, and D. G.
Edmondson, manuscript in preparation). Briefly, multiplex PCR
reactions were performed to amplify plasmid-specific regions. The
resultant PCR reactions were treated with exonuclease I and
shrimp alkaline phosphatase (Exo/SAP, U. S. Biologicals) to
remove excess nucleotides and primers, and then subjected to
allele specific primer extension (ASPE) in the presence of biotin-
dCTP using primers specific for individual plasmid products. The
59 end of the ASPE primers contains an xTAGH universal tag
sequence and the 39 end of the ASPE primers contains the
plasmid-specific sequences. The 59 universal tag sequence was
hybridized to the complementary anti-tag sequence coupled to a
particular xMAPH bead set and biotin labeled DNA was detected
with PhycoLinkH Streptavidin-R-Phycoerythrin (SAPE). Detection
and analysis was carried out using the LuminexH 200
TM System
(Luminex Corporation, Austin, TX), and samples were scored as
plasmid positive or negative based on the median fluorescence
intensity values for each probe set.
Mouse infection studies
Clones with transposon insertions in DNA recombination and
repair genes were tested individually for infectivity in 4-week-old
C3H/HeNHsd (wild type) by needle inoculation (Table 1). Mutant
clones, the parental strain 5A18NP1, and clone 5A8 were cultured
to mid-log phase, and groups of 4–5 mice were inoculated with
1610
5 organisms subcutaneously at the base of the tail as described
previously [57]. Skin biopsies were collected aseptically at day 4, 7,
14 post inoculation. The mice were sacrificed at day 28 post
inoculation, and skin, tibiotarsal joint, heart, and urinary bladder
were collected. The tissue specimens were cultured in 6 ml BSK II
medium containing kanamycin and gentamicin at 34uCi n3 %
CO2. The cultures were checked for spirochetes by dark-field
microscopy at 2 and 4 weeks, and positive cultures were diluted and
subsurface plated in 0.7% solid BSKII –agarose medium to isolate
individual colonies. For selected mutants, similar studies were
performed in 5-week-old, female C3H.C-Prkdcˆscid/ICRSmnHsd
SCID mice (Harlan, Indianapolis, IN). For clarity, this mouse strain
is referred to as C3H/scid in this article. Anti-VlsE responses were
assessed by ELISA as described previously [61].
Tick inoculation studies
B. burgdorferi mutant and wild-type strains were grown in BSK-II
medium that was supplemented with 6% rabbit serum (Pel-Freez
Biologicals) and 45.4 mg/ml rifampicin, 193 mg/ml phosphomy-
cin, 0.25 mg/ml amphotericin, 200 mg/ml kanamycin (all from
Sigma-Aldrich). Gentamicin (Gibco) at 50 mg/ml was added to the
mutant strain cultures only. Ixodes scapularis nymphal ticks from the
Tulane National Primate Research Center tick colony were
capillary fed with culture medium that contained the ruvA mutant,
ruvB mutant, or the 5A18NP1 wild type B. burgdorferi, each at a
concentration of about 9610
7 cells/ml. Capillary feeding was
performed by a procedure described previously [20]. Ticks were
then allowed to rest for 21 to 25 days in a humidified environment
at 22uC. Ten flat (unfed) nymphs from each group were surface
disinfected and crushed in 30 ml of sterile PBS. Half of this volume
was cultured in 5 ml of BSK II medium, supplemented with
antibiotics as above, for a total of 12 weeks, and monitored weekly
after the second week. . The remaining half was distributed on
microscope slides for quantitation of spirochetes (see below).
The remaining flat ticks were placed on mice. Three 8–10 week-
old C3H/HeN female mice were used for each B. burgdorferi strain,
and each mouse received 10–12 nymphs. Engorged (fed) ticks
(about 75% of the initial number) were collected within 6 days,
and cleaned, crushed, and cultured or prepared for DFA as
described above. All of the mice were euthanized 4 weeks after the
ticks had dropped off, and heart, bladder, one ear, and one
tibiotarsal joint were collected from each animal. In each case, half
of the organ sample was snap frozen in liquid nitrogen and stored
and the other half was placed in culture for 8 weeks.
Immunofluorescence
A direct fluorescent antibody (DFA) assay was performed to
evaluate survival of each B. burgdorferi strain in ticks as described
previously [62]. Briefly, tick smears from flat and fed ticks (see
above) were air-dried on glass slides, acetone fixed and stored at
220uC until DFA examination. Slides were incubated with 40 mlo f
a 1:10 dilution of fluorescein-labeled anti-Borrelia species antibody
(Kirkegaard & Perry Laboratories (Gaithersburg, MD)) for
30 minutes at 37uC. Following incubation, the slides were washed
in phosphate-buffered saline and examined by fluorescence
microscopy (magnification, 600X). For unfed ticks and for each
spirochetal strain, spirochetes in 10 microscope fields were counted
in each of 10 ticks per strain. For fed ticks, between 5 and 10 fields
were counted in 24–26 ticks per strain. The mean number of
spirochetes per field and the standard deviations are presented in
Table 4. Statistical significance (p,0.05) was assessed by ANOVA.
RFLP analysis and sequencing of amplified vlsE cassette
regions
As a screen for vlsE sequence variation, cultures obtained from
mouse infections were subjected to vlsE cassette region amplifica-
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used as the DNA template. The vlsE expression cassette was
amplified by using primers 4066 and 4120 [6] and the Phusion
TM
High-Fidelity DNA Polymerase (Finnzymes, Inc. Woburn, Mas-
sachusetts, USA). PCR reactions were performed in volumes of
50 ml containing 10 mlo f5 6HF buffer with 7.5 mM MgCl2,1ml
of 10 mM dNTPs, 1 ml of 25 mM primers, and 1 U of Phusion
TM
High-Fidelity DNA Polymerase. PCR reactions were performed in
a Eppendorf MastercyclerH thermocycler (Foster City, California,
USA), using the following conditions; 98uC for 2 min followed by
30 cycles of 1) denaturation at 98uC for 10 sec, 2) annealing at
61uC for 20 sec, and 3) extension at 72uC for 45 sec and a final
extension at 72uC for 10 min. For RFLP analysis, 10 ml of PCR
product was digested with 2.5 U of the restriction endonuclease
HphI (New England BioLabs, Ipswich, MA) for 2 hrs at 37uCi n
106NEBuffer 4. The digests were separated in a 2% (w/v) agarose
gel at a 100V constant voltage for 1.5 hrs in the presence of
ethidium bromide. The Hi-Lo
TM DNA marker (Bionexus, Oak-
land, CA) was used as a molecular size marker. Gels were imaged
with UV light illumination.
For sequence determination, the PCR products from individual
clones were amplified as described above, purified using the
QiaquickH PCR purification kit (Qiagen), and sequenced on both
strands at the High-Throughput Genomics Unit (Department of
Genome Sciences, University of Washington, Seattle), using the
same primers used for PCR amplification. Each DNA sequence
was compared with their corresponding chromatographs and the
parental vlsE sequence to verify the quality and accuracy of the
sequence data.
vlsE sequence analysis
The sequence of the vlsE cassette region of clone 5A18NP1
(GenBank GQ369288) is identical to that of B. burgdorferi B31-5A3,
from which the vlsE sequence (U76405) was derived initially [6].
All B. burgdorferi clones and the GenBank numbers corresponding
to their vlsE cassette region sequences are listed in Table S3. For
simplicity, the clone names refer to all clones resulting from
T11P01A01 infection as ruvA1 and all T03TC051 derivatives as
ruvB1. All clones resulting from infection with the parental clone
are given the prefix 5A18NP1. The clone names (e.g. Ru-
vA1SD14M1S2) are in the following format: infecting strain name;
S indicates C3H/scid mice (all others are C3H/HeN mice); D7,
D14 or D28=7, 14 or 28 days post inoculation; mouse number
(M1, M2, etc.); S, E, J, H, B=skin, ear, tibiotarsal joint, heart, and
bladder, respectively; and the clone number from that tissue. The
clone numbers and their GenBank accession numbers are also
provided at the website http://www.uth.tmc.edu/pathology/
borrelia/.
vlsE sequence analysis of variants was performed as described
previously [11]. The output of this ExcelH/Visual Basic-based
program is a color-coded map of possible vlsE recombination
events, as shown in Figure 4 and Figure S2. The minimum and
maximum deduced regions of recombination were determined by
analyzing the longest contiguous recombination event in the
variant sequence. The relationships among clones with different
vlsE sequences were displayed graphically as phylogenetic trees.
Phylogenetic trees were constructed using the online phylogenetic
program Phylogeny.fr [63], based on the aligned parental and
variant vlsE sequences.
Sensitivity to UV radiation and mitomycin C
The ruvA mutant T11P01A01 and the parental strain 5A18NP1
were tested for UV sensitivity using a modification of the method
described by Miller, et al. Cultures were grown to a density of
1610
7 organisms/ml. The spirochetes were centrifuged and
resuspended in phosphate buffered saline (PBS) at a concentration
of 1610
8 organisms/ml, and 0.1 ml of the suspensions was rapidly
aliquoted into 24-well plates. The bacteria were irradiated with
UV light (254 nm) using a Spectrolinker XL-1000 UV cross-linker
(Spectronics, Westbury, N.Y.) at doses of 0, 3.0, 4.5, 6.0, 7.5 and
9.0 mJ/cm
2. The UV treated bacteria were protected from room
light, diluted in BSK-II and cultured in BSK-II plates in duplicate
or triplicate, at a concentration of 100 organisms per plate. The
colonies were counted after 2 weeks incubation.
For determination of mitomycin C sensitivity, fresh cultures of
Borrelia were grown to mid-log phase and diluted to a density of
1610
7 organisms/ml. Mitomycin C (Sigma-Aldrich, St. Louis,
MO) was added to 1 ml cultures at final concentrations of 0, 15,
30, 60, 120, 240, 480, 960, 2000, and 4000 ng/ml, and the
cultures were incubated at 34uCi n3 %C O 2. The concentration of
motile spirochetes was determined by dark-field microscopy at 2,
4, 6, 8, 12, 16, and 24 hours. At 14 hours, the cultures were
serially diluted in BSK-II to obtain concentrations 1000 cells/ml,
and 0.1 ml portions of each dilution were cultured in BSKII plates
with antibiotics as described above. Each culture was plated in
duplicate and incubated 7–10 days at 34uC. Mitomycin C
sensitivity was measured by counting the surviving colonies.
Untreated cells grown in an identical manner served as controls.
RT-PCR analysis of ruvA operon
RNA was isolated from B. burgdorferi using RNA-BeeH (Tel-Test,
Inc., Friendswood, Texas). Borrelia cultures were grown to a
concentration of approximately 5610
7 organisms/ml. Spirochetes
from 1 ml of culture were sedimented by centrifugation and
resuspended in 1 ml of RNA-BeeH, and RNA isolation was carried
out as per manufacturer’s instructions. The resulting RNA was
quantitated by UV spectroscopy, checked visually on an agarose
gel, and then treated with DNase I (RNase-free, New England
Biolabs) following the manufacturer’s suggested procedure.
Reverse transcription was performed using 200 ng of RNA and
primers specific to the ruvA operon following the two-step protocol
found in the Enhanced Avian HS RT-PCR kit from Sigma-
Aldrich. Subsequent PCR reactions used two ml of the resultant
cDNA, 25 mM of specific primers and 2X PCR mix from New
England Biolabs. Primer sequences and reaction conditions are
shown in Table S2.
Supporting Information
Figure S1 Gene arrangement and transcription patterns of the
ruvAB locus in the parental clone 5A18NP1 and the ruvA mutant
T11P01A01. (A) The ruvAB locus, with presumed cotranscribed
genes queA and pfpB. The location of the transposon insertion site
in the ruvA mutant T11P01A01 is shown. (B) RT-PCR analysis of
transcription of the ruvAB locus of 5A18NP1 and T11P01A01,
using the primer pairs shown in (A). RT=with reverse
transcriptase, no RT=without reverse transcriptase.
Found at: doi:10.1371/journal.ppat.1000679.s001 (0.26 MB PDF)
Figure S2 Detailed analysis of the possible recombination events
in the vlsE variant clonotypes isolated 28 days post inoculation of
C3H/HeN mice with the ruvA mutant T11P01A01 and the ruvB
mutant T03TC051. The method of analysis is described in detail
in Ref. [11]. Briefly, the horizontal colored bars represent regions
of each silent cassette (vls2 to vls16, top to bottom) that may have
contributed to sequence changes found in the variant clone. Dark
regions in each bar correspond to the regions of sequence changes,
whereas the lighter portion of each bar represents the maximal
possible region of that silent cassette that could have been
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The locations and silent cassette sources of the most likely
recombination events are marked by a red dashed box.
Found at: doi:10.1371/journal.ppat.1000679.s002 (0.65 MB PDF)
Figure S3 Reduced vlsE sequence diversity generated following
inoculation of C3H/HeN mice with the ruvB mutant T03TC051.
Clones were isolated from three C3H/HeN mice 28 days post
inoculation with 10
5 T03TC051. The vlsE cassette region
sequences of each clone were optimally aligned and then analyzed
for sequence diversity using a phylogenetic tree program. The
groups of clones isolated from each mouse and their tissue source
are indicated. Trees are rooted with the 5A18NP1 parental vlsE
sequence.
Found at: doi:10.1371/journal.ppat.1000679.s003 (0.08 MB PDF)
Table S1 The B. burgdorferi ruvA mutant T11P01A01 and the
ruvB mutant T03TC051 exhibit decreased vlsE sequence variation
during infection of C3H/HeN and C3H/SCID mice.
Found at: doi:10.1371/journal.ppat.1000679.s004 (0.01 MB PDF)
Table S2 Primers used in RT-PCR of the ruvAB locus.
Found at: doi:10.1371/journal.ppat.1000679.s005 (0.01 MB PDF)
Table S3 B. burgdorferi isolates generated in this study.
Found at: doi:10.1371/journal.ppat.1000679.s006 (0.43 MB PDF)
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